This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier Signs Strategic Collaboration Agreement With People's Medical Publishing House, China

Stocks in this article: ENLRUK

NEW YORK, June 6, 2013 /PRNewswire/ --

New milestone in expanding cooperation with the leading Chinese medical publisher

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today signed a strategic collaboration agreement with People's Medical Publishing House (PMPH), China. The announcement expands on Elsevier's current publishing collaboration with the largest Chinese medical publisher in China.

Elsevier's collaboration with PMPH goes back to the 1990s. Since then PMPH has translated and published hundreds of Elsevier's book titles in health sciences. Under the new agreement, Elsevier and PMPH will deepen and expand their collaboration, not only translating English book titles into Chinese and vice versa, but now also facilitating international collaboration in authoring books and developing information products, as well as enabling distribution of these books and  products to health professionals globally.

"It is part of our global strategy to continue to work with Elsevier," said Mr. Chen Xianyi, Chairman and President of PMPH. "With abundant resources from China's top medical universities, research institutions and hospitals, PMPH has great relationships in medical publishing. Our collaboration with Elsevier will improve our practices in digital publishing and diversification, and facilitate our process of transiting from a domestic publishing company to an international publishing group."

"At Elsevier, we are committed to deliver world-class medical content and user-friendly databases to our customers around the world," said Gerrit Bos, Managing Director of Elsevier Health Sciences APAC. "Our strategic collaboration agreement with PMPH is a great step in providing access to top class medical resources for more clinicians, students and experts in medical professions in China."

About People's Medical Publishing House

People's Medical Publishing House Co., Ltd (PMPH) is the leading medical publisher in China. It produces books, journals and e-products including medical textbooks, clinical references, and patient education books both in western medicine and Traditional Chinese Medicine (TCM). PMPH publishes 3000 new titles and new editions annually and has prestigious local and international author teams.

PMPH is headquartered in Beijing and employs more than 1000 people in and outside China. The company has 10 wholly-owned subsidiaries, including PMPH- USA, the Radegast Lakeview Hotel and Conference Center in Beijing, the PMPH Printing House, and the Beijing International Exhibition Company.

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact Rose Wang Elsevier, APAC +86-10-8520-8866 r.wang@elsevier.com

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs